Docosahexaenoic Acids

major facilitator superfamily domain containing 2A ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33482601 Structured form of DHA prevents neurodegenerative disorders: A better insight into the pathophysiology and the mechanism of DHA transport to the brain. 2021 Jan 1
2 33738958 Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases. 2021 May 2
3 34229049 Mfsd2a overexpression alleviates vascular dysfunction in diabetic retinopathy. 2021 Sep 3
4 32117064 Child Head Circumference and Placental MFSD2a Expression Are Associated to the Level of MFSD2a in Maternal Blood During Pregnancy. 2020 5
5 32705603 Mfsd2a: A Physiologically Important Lysolipid Transporter in the Brain and Eye. 2020 4
6 33186761 Novel neuroclinical findings of autosomal recessive primary microcephaly 15 in a consanguineous Iranian family. 2020 Dec 2
7 31681849 Zika virus degrades the ω-3 fatty acid transporter Mfsd2a in brain microvascular endothelial cells and impairs lipid homeostasis. 2019 Oct 3
8 31861865 Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer's Disease. 2019 Dec 20 4
9 29206689 Placental fatty acid transfer. 2018 Mar 1
10 29844613 Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a. 2018 May 29 3
11 30043326 Homozygous mutation in MFSD2A, encoding a lysolipid transporter for docosahexanoic acid, is associated with microcephaly and hypomyelination. 2018 Dec 3
12 26869380 Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes. 2017 Apr 4
13 28827082 MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice. 2017 Nov 2
14 26005868 Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome. 2015 Jul 5